Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/05/014051
CTRI/2018/05/014051
Not yet recruiting
未知

A PROSPECTIVE STUDY OF ADVERSE DRUG REACTIONS IN OPHTHALMOLOGY IN A TERTIARY CARE HOSPITA

KIMs Hospital and reasearch center0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- N/A

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- N/A
Sponsor
KIMs Hospital and reasearch center
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
KIMs Hospital and reasearch center

Eligibility Criteria

Inclusion Criteria

  • •1\.All subjects both inpatients and outpatients above 18yrs of age of either gender with suspected ADR.
  • •2\.ADR(ocular and extraocular) due to ophthalmic drugs
  • •3\.Ocular ADR due to systemic drugs
  • •4\.Willingness to give written informed consent and available for follow up, if any.

Exclusion Criteria

  • •1\.Reactions due to over dosage of drugs.
  • •2\.Adverse drug reactions due to medicines of alternative systems like Ayurveda ,Homeopathy, Unani etc.
  • •3\.Reactions due to blood and blood products.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation of Adverse Drug Reactions in patients receiving Antiretroviral TherapyHealth Condition 1: B20- Human immunodeficiency virus [HIV]disease
CTRI/2024/05/067521Government Medical College
Not yet recruiting
Not Applicable
Profile of adverse drug reaction in children suffering from cancer in a hospital setting
CTRI/2023/11/059711Government Medical College Jammu
Completed
Not Applicable
adverse drug reactions and quality of life with anti-hiv treatmentHealth Condition 1: null- HIV positive
CTRI/2019/02/017398Dr Ruchika Irene Dillu100
Not yet recruiting
Not Applicable
A study to capture the side effects and Quality of life(QoL) in castration-resistant prostate cancer patients who are receiving docetaxel as part of standard therapy in Tata Memorial Centre.Health Condition 1: C61- Malignant neoplasm of prostate
CTRI/2019/09/021080Tata Memorial Centre
Completed
Phase 4
To study the nature,mechanism and common drug class involved in possible drug-drug interactions in emergency medicine department patients admitted for at least two days in emergency department wards.Health Condition 1: O- Medical and Surgical
CTRI/2020/01/022913Kempegowda Institute of Medical Sciences110